N Aoki

8 papers receiving 144 citations

Peers

N Aoki
Comparison fields: 5 of 55
  • Clinical Biochemistry 59
  • Drug Discovery 1
  • Infectious Diseases 85
  • Applied Microbiology and Biotechnology 7
  • Critical Care and Intensive Care Medicine 15
Replace Julie D. Seroogy with:
Julie D. Seroogy United States
J. D. Wolny United States
Dagmara I. Moscoso United States
Robert Skinner United States
Mayank Dwivedi India
Sara Grillo Spain
Michel Leneveu France
Nanna Reiter Denmark
Κωνσταντίνος Κωνσταντίνου Greece
Raj Palraj United States
N Aoki relative to Julie D. Seroogy United States Julie D. Seroogy's profile →
Citations per field
00.5×1.5×1.9×
Julie D. Seroogy · 1×
Citations per year

Countries citing papers authored by N Aoki

Since Specialization
Citations

This map shows the geographic impact of N Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Aoki more than expected).

Fields of papers citing papers by N Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Aoki. The network helps show where N Aoki may publish in the future.

Co-authors

The 25 scholars most cited alongside N Aoki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N Aoki Line = papers co-authored together N Aoki links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 2007103
2 200029
3 201813
4 20234
5
[Clinical pharmacology and efficacy of levofloxacin in elderly patients].
19924
6 20071
7
[Clinical pharmacology and efficacy of S-1108].
19931
8
THE EFFECT OF CELECOXIB, A CYCLOOXYGENASE-2 INHIBITOR, IN FAMILIAL ADENOMATOUS POLYPOSIS
20001
9 20250

About N Aoki

N Aoki is a scholar working on Organic Chemistry, Pharmacology, Infectious Diseases, Surgery and Molecular Biology, having authored 9 papers that have together received 156 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (1 paper), Oral and gingival health research (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper), Cystic Fibrosis Research Advances (1 paper), Traditional and Medicinal Uses of Annonaceae (1 paper), Bacterial biofilms and quorum sensing (1 paper), Synthesis and Biological Activity (1 paper) and Laser-Plasma Interactions and Diagnostics (1 paper). The work is most often cited by research in Clinical Biochemistry (59 citations), Drug Discovery (1 citation), Infectious Diseases (85 citations), Applied Microbiology and Biotechnology (7 citations) and Critical Care and Intensive Care Medicine (15 citations). N Aoki has collaborated with scholars based in Japan and United States. Frequent co-authors include Naoki Aikawa, Y Niki, Rodney Croos‐Dabrera, S Kohno, Yoshinobu Sumiyama, Shinichi Watanabe, Kenneth J. Tack, K Yamaguchi, Hiroyuki Matsuoka and Akira Ishii. Their work appears in journals such as Review of Scientific Instruments, International Journal of Antimicrobial Agents, Journal of Antimicrobial Chemotherapy, Journal of Clinical and Experimental Dentistry and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact